关注
Yingkun Xu
Yingkun Xu
在 mail.sdu.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma
G Wu, Q Wang, Y Xu, Q Li, L Cheng
Aging (Albany NY) 12 (14), 14933, 2020
812020
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
G Wu, Q Wang, Y Xu, J Li, H Zhang, G Qi, Q Xia
Cell death & disease 10 (6), 416, 2019
662019
Glycolysis‐related genes serve as potential prognostic biomarkers in clear cell renal cell carcinoma
Y Zhang, M Chen, M Liu, Y Xu, G Wu
Oxidative medicine and cellular longevity 2021 (1), 6699808, 2021
482021
Screening and identification of key biomarkers for bladder cancer: a study based on TCGA and GEO data
Y Xu, G Wu, J Li, J Li, N Ruan, L Ma, X Han, Y Wei, L Li, H Zhang, Y Chen, ...
BioMed Research International 2020 (1), 8283401, 2020
452020
Roles of reactive oxygen species in biological behaviors of prostate cancer
C Han, Z Wang, Y Xu, S Chen, Y Han, L Li, M Wang, X Jin
BioMed research international 2020 (1), 1269624, 2020
382020
Porcupine inhibitor LGK974 downregulates the Wnt signaling pathway and inhibits clear cell renal cell carcinoma
J Li, G Wu, Y Xu, J Li, N Ruan, Y Chen, Q Zhang, Q Xia
BioMed Research International 2020 (1), 2527643, 2020
342020
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF‐κB Axis
C Han, Z Wang, S Chen, L Li, Y Xu, W Kang, C Wei, H Ma, M Wang, X Jin
Oxidative medicine and cellular longevity 2021 (1), 8851763, 2021
312021
FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma
G Wu, Y Xu, Q Wang, J Li, L Li, C Han, Q Xia
European Journal of Pharmacology 862, 172637, 2019
312019
A new prognostic risk model based on PPAR pathway‐related genes in kidney renal clear cell carcinoma
Y Xu, X Li, Y Han, Z Wang, C Han, N Ruan, J Li, X Yu, Q Xia, G Wu
PPAR research 2020 (1), 6937475, 2020
232020
RPN2 predicts poor prognosis and promotes bladder cancer growth and metastasis via the PI3K-Akt pathway
C Han, S Chen, H Ma, X Wen, Z Wang, Y Xu, X Jin, X Yu, M Wang
OncoTargets and therapy, 1643-1657, 2021
152021
TRIM33 overexpression inhibits the progression of clear cell renal cell carcinoma in vivo and in vitro
Y Xu, G Wu, J Zhang, J Li, N Ruan, J Zhang, Z Zhang, Y Chen, Q Zhang, ...
BioMed Research International 2020 (1), 8409239, 2020
152020
Cuprotosis‐Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients
Y Xu, H Li, A Lan, Q Wu, Z Tang, D Shu, Z Tan, X Liu, Y Liu, S Liu
Journal of Oncology 2022 (1), 2363043, 2022
122022
Development and Validation of a Novel PPAR Signaling Pathway‐Related Predictive Model to Predict Prognosis in Breast Cancer
Y Xu, D Shu, M Shen, Q Wu, Y Peng, L Liu, Z Tang, S Gao, Y Wang, S Liu
Journal of immunology research 2022 (1), 9412119, 2022
112022
The role of prostate-specific antigen and multiparametric magnetic resonance imaging in the diagnosis of granulomatous prostatitis induced by intravesical bacillus Calmette …
Z Wang, C Han, Y Xu, X Yu, W Kang, Y Xiang, Y Yuan, L Li, M Wang
Journal of Cancer Research and Therapeutics 17 (3), 625-629, 2021
102021
A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma
G Wu, Y Xu, H Zhang, Z Ruan, P Zhang, Z Wang, H Gao, X Che, Q Xia, ...
Bioengineered 12 (1), 7805-7819, 2021
102021
Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N6‐Methyladenosine RNA Methylation Regulators
Y Zhang, Y Yao, X Qi, J Li, M Liu, X Che, Y Xu, G Wu
Journal of Immunology Research 2021 (1), 6617841, 2021
102021
LAPTM5 plays a key role in the diagnosis and prognosis of testicular germ cell tumors
X Li, Y Su, J Zhang, Y Zhu, Y Xu, G Wu
International Journal of Genomics 2021 (1), 8816456, 2021
102021
Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis‐Related Genes in Breast Cancer
Y Xu, Y Jin, S Gao, Y Wang, C Qu, Y Wu, N Ding, Y Dai, L Jiang, S Liu
Journal of Oncology 2022 (1), 7204415, 2022
92022
ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β‐Catenin Signaling Pathway
P Zhang, Y Xu, S Chen, Z Wang, L Zhao, C Chen, W Kang, R Han, J Qiu, ...
Journal of Oncology 2022 (1), 2724515, 2022
92022
Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
G Wu, Y Xu, L Li, J Li, N Ruan, J Dong, Z Si, Q Xia, Q Wang
International journal of medical sciences 17 (18), 2905, 2020
92020
系统目前无法执行此操作,请稍后再试。
文章 1–20